ABVC — ABVC BIOPHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $1.3M | +5042.7% | -$4.1M | — | -31.5% | 100.0% | -256.6% | — | — | — | — |
Revenue YoY trend Net margin trend
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 14 SEC-registered investment managers reported holding ABVC (ABVC BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $1.40M across 1.32M shares. That is +36.8% by share count (+326.22K shares) versus the previous quarter, while reported value moved -8.2%. Ownership is concentrated: the five largest holders account for 86.1% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 4 opened new positions, 5 added to existing stakes, 1 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ABVC BIOPHARMA INC (ABVC) include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, ranked by reported 13F value among the 38 institutional holders on this page.
ABVC is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 14 | 1.32M | $1.40M | +35.9% |
| Q2 2026 | 14 | 1.18M | $1.87M | +40.8% |
| Q1 2026 | 13 | 827.23K | $802.50K | +0.2% |
| Q4 2025 | 15 | 875.01K | $1.86M | +9.6% |
| Q3 2025 | 15 | 804.93K | $2.45M | +88.2% |
| Q2 2025 | 9 | 367.38K | $817.41K | +31.8% |
| Q1 2025 | 10 | 287.50K | $304.75K | +37.8% |
| Q4 2024 | 13 | 409.23K | $241.04K | +54.3% |
Over the 8 quarters shown, institutional share counts increased 222% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+88.2%).
Top Institutional Holders (Q3 2026) — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 569.15K | $603.30K | 0.00% | Add | |
| 236.73K | $250.99K | 0.00% | Add | |
| 139.18K | $147.53K | 0.00% | Add | |
| 97.36K | $103.20K | 0.00% | Hold | |
| 91.30K | $96.78K | 0.00% | Add | |
| 56.44K | $59.83K | 0.00% | Hold | |
| 48.64K | $51.56K | 0.00% | Hold | |
| 36.68K | $38.88K | 0.00% | Hold | |
| 29.43K | $31.19K | 0.00% | Add | |
| 11.39K | $12.07K | 0.00% | New | |
| 6 | $6 | 0.00% | New | |
| 2 | $2 | 0.00% | New | |
| 1 | $1 | 0.00% | New | |
| 1 | $1 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 374.50K | $591.71K | 0.00% | Add | |
| 228.04K | $360.38K | 0.00% | New | |
| 228.04K | $360.38K | 0.00% | Add | |
| 97.36K | $153.83K | 0.00% | Hold | |
| 56.44K | $89.18K | 0.00% | Hold | |
| 48.64K | $76.86K | 0.00% | Add | |
| 48.28K | $76.28K | 0.00% | New | |
| 36.68K | $57.96K | 0.00% | New | |
| 34.12K | $53.91K | 0.00% | Add | |
| 20.06K | $31.69K | 0.00% | Add | |
| 11.60K | $18.33K | 0.00% | New | |
| 540 | $853 | 0.00% | New | |
| 300 | $474 | 0.00% | New | |
| 6 | $9 | 0.00% | New |
Q1 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 221.17K | $214.60K | 0.00% | Add | |
| 190.57K | $184.86K | 0.00% | New | |
| 97.36K | $94.44K | 0.00% | New | |
| 95.10K | $92.26K | 0.00% | Reduce | |
| 72.80K | $70.62K | 0.00% | Hold | |
| 56.44K | $54.75K | 0.00% | Hold | |
| 32.09K | $31.13K | 0.00% | Hold | |
| 21.02K | $20.39K | 0.00% | New | |
| 12.23K | $11.86K | 0.00% | New | |
| 10.70K | $10.38K | 0.00% | Reduce | |
| 10.55K | $10.23K | 0.00% | New | |
| 5.42K | $5.26K | 0.00% | Add | |
| 1.77K | $1.72K | 0.00% | Reduce |
Q4 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 287.94K | $613.31K | 0.00% | Add | |
| 202.37K | $431.12K | 0.00% | Add | |
| 114.26K | $243.38K | 0.00% | Add | |
| 72.80K | $155.06K | 0.00% | Hold | |
| 56.44K | $120.22K | 0.00% | Hold | |
| 55.54K | $118.31K | 0.00% | Add | |
| 32.09K | $68.34K | 0.00% | Add | |
| 20.10K | $42.81K | 0.00% | New | |
| 11.26K | $23.99K | 0.00% | Reduce | |
| 10.87K | $23.15K | 0.00% | New | |
| 5.17K | $11.02K | 0.00% | New | |
| 3.19K | $6.80K | 0.00% | Add | |
| 2.59K | $5.51K | 0.00% | Add | |
| 196 | $417 | 0.00% | Reduce | |
| 189 | $402 | 0.00% | Add |
Q3 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 267.45K | $813.05K | 0.00% | Add | |
| 187.81K | $571.08K | 0.00% | Add | |
| 110.50K | $335.92K | 0.00% | Add | |
| 72.80K | $221.31K | 0.00% | Add | |
| 56.44K | $171.58K | 0.00% | New | |
| 24.82K | $75.46K | 0.00% | Reduce | |
| 24.80K | $75.39K | 0.00% | Reduce | |
| 19.60K | $59.59K | 0.00% | New | |
| 19.60K | $59.59K | 0.00% | New | |
| 15.66K | $47.62K | 0.00% | New | |
| 2.15K | $6.55K | 0.00% | Add | |
| 1.85K | $5.62K | 0.00% | New | |
| 1.11K | $3.00K | 0.00% | New | |
| 175 | $532 | 0.00% | Add | |
| 150 | $456 | 0.00% | New |
Q2 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 111.53K | $248.16K | 0.00% | Add | |
| 110.50K | $245.86K | 0.00% | Add | |
| 52.62K | $117.09K | 0.01% | Reduce | |
| 41.71K | $92.80K | 0.00% | New | |
| 37.14K | $82.64K | 0.00% | Add | |
| 12.90K | $28.70K | 0.00% | Hold | |
| 483 | $1.07K | 0.00% | Add | |
| 354 | $788 | 0.00% | Reduce | |
| 133 | $296 | 0.00% | Add |
New Positions (Q3 2026)
- Squarepoint Ops LLC 11.39K sh · $12.07K
- Robinhood Markets, Inc. 6 sh · $6
- BARCLAYS PLC 2 sh · $2
- SBI Securities Co., Ltd. 1 sh · $1
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 228.04K sh · $360.38K
- XTX Topco Ltd sold 48.28K sh · $76.28K
- JANE STREET GROUP, LLC sold 20.06K sh · $31.69K
- Citigroup Inc sold 540 sh · $853
- LifeSteps Financial, Inc. sold 300 sh · $474
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 569.15K | 374.50K | 190.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 236.73K | 228.04K | 221.17K | 202.37K | 187.81K | 110.50K | 104.48K | 79.28K | 71.61K | 55.23K | 22.00K | 19.48K | 19.48K | 139.28K | 139.28K | 139.28K | 139.65K | 49.91K | 49.91K | 49.91K |
| UBS Group AG | 139.18K | 34.12K | 1.77K | 2.59K | 1.85K | — | 29.00K | 10 | — | — | — | — | — | — | — | 4.28K | — | — | 1.27K | 7.66K |
| VANGUARD FIDUCIARY TRUST CO | 97.36K | 97.36K | 97.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 91.30K | — | 72.80K | 72.80K | 72.80K | 12.90K | 12.90K | 12.90K | 12.90K | 12.90K | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 56.44K | 56.44K | 56.44K | 56.44K | 56.44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 48.64K | 48.64K | 32.09K | 32.09K | 24.82K | 37.14K | 19.14K | 19.14K | 19.14K | 19.14K | — | — | — | 18.42K | 18.42K | 18.42K | 18.42K | — | — | — |
| PANAGORA ASSET MANAGEMENT INC | 36.68K | 36.68K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 29.43K | 11.60K | — | 55.54K | 15.66K | — | — | 40.74K | — | 25.21K | — | 27.16K | 15.59K | — | — | — | 12.61K | — | — | — |
| Squarepoint Ops LLC | 11.39K | — | 10.55K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 1 | — | — | — | — | 483 | 460 | 662 | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 1 | 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SIMPLEX TRADING, LLC | — | — | — | 196 | 1.11K | — | — | — | — | — | — | 13.60K | 113.50K | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 287.94K | 267.45K | 111.53K | 46.95K | 46.95K | 46.95K | 46.95K | 46.95K | 27.25K | 18.32K | 387.51K | 387.51K | 375.51K | 375.14K | 375.14K | 375.14K | 372.76K |
| GROUP ONE TRADING LLC | — | — | — | — | — | — | — | — | — | 1.00K | — | 38.80K | 43.10K | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 228.04K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | 95.10K | 114.26K | 110.50K | 41.71K | — | — | — | — | — | 36.10K | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | — | 20.06K | 10.70K | 10.87K | — | — | — | — | — | — | — | 18.80K | 13.80K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ABVC?
As of 2026-Q3, 14 institutional funds reported holding ABVC (ABVC BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $1.40M.
How many shares of ABVC do institutions own?
13F filers reported 1.32M shares of ABVC, worth $1.40M in aggregate at the end of 2026-Q3.
Is institutional ownership of ABVC rising or falling?
Share counts moved +36.8% versus the prior quarter — accumulation.
Who are the top institutional holders of ABVC?
The largest 13F holders are Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, CHASE INVESTMENT COUNSEL CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ABVC BIOPHARMA INC?
The major shareholders of ABVC BIOPHARMA INC (ABVC) by reported 13F value are Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, CHASE INVESTMENT COUNSEL CORP, among 38 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.